A case of Peripartum Cardiomyopathy in Preeclamptic Toxemia.

Peripartum cardiomyopathy is a erratic type of increased cardiomyopathy presenting with heart failure subordinate to left ventricular systolic dysfunction to the end of pregnancy or in the puerperium. The American heart association & European society of cardiology has defined this condition as considered it as a diagnosis of exclusion. Echocardiographic findings include ejection fraction(EF) of nearly below 45% and/or Fractional shortening of less than 30% or End-diastolic dimension of more than 2.7 cm/m2. Incidence of PPCM is around 1 in 2000 with a fatality rate of 20-50%. Known risk factors are advanced maternal age, gestational hypertension, preeclampsia, multiparity, multiple gestations, African American race, obesity, malnutrition , diabetes, substance and tobacco abuse and family history.